DE19980080D2 - Inhibition of modulation of DNA caused by mutant p53 - Google Patents

Inhibition of modulation of DNA caused by mutant p53

Info

Publication number
DE19980080D2
DE19980080D2 DE19980080T DE19980080T DE19980080D2 DE 19980080 D2 DE19980080 D2 DE 19980080D2 DE 19980080 T DE19980080 T DE 19980080T DE 19980080 T DE19980080 T DE 19980080T DE 19980080 D2 DE19980080 D2 DE 19980080D2
Authority
DE
Germany
Prior art keywords
mutant
inhibition
modulation
dna caused
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19980080T
Other languages
German (de)
Inventor
Wolfgang Willi Deppert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE19980080T priority Critical patent/DE19980080D2/en
Application granted granted Critical
Publication of DE19980080D2 publication Critical patent/DE19980080D2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE19980080T 1998-01-26 1999-01-22 Inhibition of modulation of DNA caused by mutant p53 Ceased DE19980080D2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19980080T DE19980080D2 (en) 1998-01-26 1999-01-22 Inhibition of modulation of DNA caused by mutant p53

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19802792A DE19802792A1 (en) 1998-01-26 1998-01-26 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer
PCT/DE1999/000221 WO1999037803A2 (en) 1998-01-26 1999-01-22 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
DE19980080T DE19980080D2 (en) 1998-01-26 1999-01-22 Inhibition of modulation of DNA caused by mutant p53

Publications (1)

Publication Number Publication Date
DE19980080D2 true DE19980080D2 (en) 2001-03-29

Family

ID=7855657

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19802792A Withdrawn DE19802792A1 (en) 1998-01-26 1998-01-26 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer
DE19980080T Ceased DE19980080D2 (en) 1998-01-26 1999-01-22 Inhibition of modulation of DNA caused by mutant p53

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19802792A Withdrawn DE19802792A1 (en) 1998-01-26 1998-01-26 Inhibiting DNA modulation caused by p53 mutant, useful for treatment of cancer

Country Status (13)

Country Link
EP (1) EP1049810A2 (en)
JP (1) JP2002507389A (en)
KR (1) KR100413929B1 (en)
CN (1) CN1289373A (en)
AU (1) AU755775B2 (en)
BR (1) BR9907725A (en)
CA (1) CA2318313A1 (en)
DE (2) DE19802792A1 (en)
NO (1) NO20003762D0 (en)
PL (1) PL342399A1 (en)
RU (1) RU2235786C2 (en)
SK (1) SK11052000A3 (en)
WO (1) WO1999037803A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100348113C (en) * 2005-05-14 2007-11-14 章建庆 Method for preparing edible indica rice grass carp

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
GB9521544D0 (en) * 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof

Also Published As

Publication number Publication date
CA2318313A1 (en) 1999-07-29
JP2002507389A (en) 2002-03-12
NO20003762L (en) 2000-07-21
WO1999037803A3 (en) 1999-10-14
AU755775B2 (en) 2002-12-19
NO20003762D0 (en) 2000-07-21
PL342399A1 (en) 2001-06-04
KR100413929B1 (en) 2004-01-07
AU2920099A (en) 1999-08-09
CN1289373A (en) 2001-03-28
EP1049810A2 (en) 2000-11-08
WO1999037803A2 (en) 1999-07-29
RU2235786C2 (en) 2004-09-10
WO1999037803A9 (en) 1999-11-18
DE19802792A1 (en) 1999-07-29
BR9907725A (en) 2001-09-04
KR20010040407A (en) 2001-05-15
SK11052000A3 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
DE69928195D1 (en) Completion of Untrerdruck-boreholes
DE69941116D1 (en) G OF GDF-8
DK1105413T3 (en) Hepatitis C inhibitor tripeptides
DK1004669T3 (en) Newly differentiated inhibitor
DE60033896D1 (en) Differentiation of modulation types
ID24638A (en) COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
FI4209U1 (en) New compounds
ATE264069T1 (en) REINFORCEMENT OF FOODS
ATE231521T1 (en) CRYSTALLINE FORMS OF ETO2C-CH2-(R)CGL-AZE-PAB-OH
DE69839679D1 (en) ACTION OF DIFFERENT PROTOCOLS
DE69921311D1 (en) REPRODUCTION OF NUCLEIC ACIDS
DE69907146T2 (en) DIRECT OXIDATION OF CYCLOALCANES
DE69837659D1 (en) Blind detection of modulation
DE69809647D1 (en) Overwrite phase change media
DE69927878D1 (en) Coating of bituminous substrates
DE69908951D1 (en) CRYSTAL FORMS OF OSANETANT
DE69927626D1 (en) Execution of permutations
DE69718506T2 (en) NEW USE OF CREATINE
DE19980080D2 (en) Inhibition of modulation of DNA caused by mutant p53
ID23757A (en) COMPOSITION OF IMPROVING MATERIALS
DE69811256D1 (en) POLYMORPHIC MODIFICATIONS OF DOFETILID
DE69716598D1 (en) STABILIZATION OF PAINTS BY SPIROINDER DERIVATIVES
DE69905621D1 (en) 3- (THIO-SUBSTITUTED AMIDO) LACTAME, USED AS INHIBITORS OF THE MATRIX METALLOPROTEINASE
ATE317853T1 (en) BINDING INHIBITION OF THE H COMPLEMENT FACTOR
SE9801397D0 (en) Novel compounds

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: A61K 39395

8131 Rejection